iRhythm Technologies Plans to Share Q3 2024 Financial Results
iRhythm Technologies, Inc. (NASDAQ: IRTC), a prominent player in digital healthcare, has announced a significant update regarding its third quarter financial performance. The company is dedicated to offering innovative solutions that enhance disease detection, prevention, and management. On October 30, 2024, after the conclusion of the trading day, iRhythm will unveil its financial results for the third quarter of 2024.
Key Details of the Financial Report
The management of iRhythm is scheduled to host a conference call that will begin at 1:30 p.m. PT (4:30 p.m. ET) on the same day. This call will provide an opportunity for investors, analysts, and stakeholders to gain insights into the company's financial health and strategic direction.
How to Access the Conference Call
Investors and interested parties can access the conference call through the company's investor relations website. A live webcast will be available, as well as an archived version for those who are unable to join in real time. To find the presentation, visit the “Events & Presentations” section of the investor website.
About iRhythm Technologies
Founded with the mission of transforming the landscape of healthcare, iRhythm Technologies is at the forefront of digital health innovation. The company merges cutting-edge wearable biosensors and cloud-based data analytics with sophisticated proprietary algorithms. This combination allows iRhythm to convert data from millions of heartbeats into actionable clinical insights.
Commitment to Patient Care
iRhythm’s relentless focus on enhancing patient care has positioned it as a leader in its field. The vision is to deliver better data, better insights, and better health outcomes for all, fundamentally changing how diseases are detected and managed.
Connect with iRhythm Technologies
For any inquiries regarding investments or media relations, iRhythm provides dedicated contact avenues. Investors can connect with Stephanie Zhadkevich for investor relations, while media inquiries can be directed to Kassandra Perry. Both individuals can be reached via their respective email addresses, which can be found on the iRhythm investor relations page.
Frequently Asked Questions
When will iRhythm Technologies report its Q3 2024 results?
iRhythm Technologies is scheduled to report its Q3 2024 results on October 30, 2024.
What is the format of the Q3 2024 financial results presentation?
The presentation will be in the form of a conference call open to investors and stakeholders.
How can I access the live conference call?
The live conference call will be accessible through the investor relations section of iRhythm's website.
Who can I contact for investor relations?
For investor relations, you can contact Stephanie Zhadkevich via the emails provided on iRhythm's investor relations page.
What does iRhythm Technologies specialize in?
iRhythm Technologies specializes in creating digital healthcare solutions that detect, predict, and prevent diseases through advanced technology.
